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Key findings: 
• Using gene expression data from the GUDMAP database, we selected Sema3f as an 
anti-angiogenic candidate gene that may exclude developing blood vessels from the 
cap mesenchyme (groups of nephron progenitor cells) in the murine metanephric 
(permanent) kidney. 
• In the developing kidney, Sema3f is expressed in the cap mesenchyme, and its 
receptor, Nrp2, is expressed in endothelia that pattern in cycles around the caps in 
the nephrogenic zone.  
• Genetic ablation of Sema3f and of Nrp2 in mice demonstrated that they are not 
required for vascular exclusion from the cap mesenchyme. 
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Abstract 
Background: During murine kidney development, new cortical blood vessels form and 
pattern in cycles that coincide with cycles of collecting duct branching and the accompanying 
splitting of the cap mesenchyme (nephron progenitor cell populations that ‘cap’ collecting 
duct ends). At no point in the patterning cycle do blood vessels enter the cap mesenchyme. 
We hypothesised that the exclusion of blood vessels from the cap mesenchyme may be 
controlled, at least in part, by an anti-angiogenic signal expressed by the cap mesenchyme 
cells. 
Results: We show that semaphorin-3f (Sema3f), a known anti-angiogenic factor, is 
expressed in cap mesenchymal cells and its receptor, neuropilin-2 (Nrp2), is expressed by 
newly forming blood vessels in the cortex of the developing kidney. We hypothesised that 
Sema3f/Nrp2 signalling excludes vessels from the cap mesenchyme. Genetic ablation of 
Sema3f and of Nrp2, however, failed to result in vessels invading the cap mesenchyme.  
Conclusions: Despite their complementary expression patterns, our data suggest that 
Sema3f and Nrp2 are dispensable for the exclusion of vessels from the cap mesenchyme 
during kidney development. These results should provoke additional experiments to 
ascertain the biological significance of Sema3f/Nrp2 expression in the developing kidney.  
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Introduction 
In his Collected Essays, T.H. Huxley referred to ‘The great tragedy of Science – the slaying 
of a beautiful hypothesis by an ugly fact’. This report describes just such a slaying, of a 
hypothesis about how the arrangement of blood vessels is controlled in the developing 
kidney. 
The major function of the adult kidney is to filter blood. Blood enters the kidneys via the renal 
arteries before being transported to the glomerular capillaries where small molecules are 
filtered into the Bowman’s capsule. After filtration, useful molecules are reabsorbed by 
tubular cells and collected by peritubular capillaries, while waste and toxins are excreted as 
urine. This task requires a complex vasculature that must be assembled accurately during 
development.  
Mouse metanephric (permanent) kidney development begins at E10.5 when the ureteric bud, 
the precursor of the collecting duct and ureter, evaginates from the caudal end of the 
Wolffian/nephric duct in response to glial cell-line-derived neurotrophic factor (GDNF; Sainio 
et al., 1997; Costantini & Kopan, 2010). The ureteric bud invades a mass of undifferentiated 
cells, the metanephrogenic mesenchyme, and begins to branch. As the ureteric bud 
branches, it induces nephron formation by provoking groups of nephron progenitor cells to 
undergo mesenchymal-to-epithelial transitions (Carroll et al., 2005). The nephron progenitor 
cells reciprocate by inducing branching of the ureteric bud (Majumdar et al., 2003; Costantini 
& Shakya, 2006; Cebrian et al., 2014). Prior to their differentiation, nephron progenitor cells 
situate around ureteric bud tips in cell populations known as the cap mesenchyme (they ‘cap’ 
the ureteric tips: Reinhoff, 1922). As the ureteric bud bifurcates, the overlaying cap 
mesenchymal population splits so that each new ureteric tip inherits a population of cap 
mesenchymal cells; this occurs in cycles throughout kidney development (Short et al., 2014).  
Recently, we have shown that blood vessels pattern in cycles alongside the splitting of the 
cap mesenchyme and the branching of the ureteric bud in the developing kidney (Munro et 
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al., 2017). Vascular plexuses form around the cap mesenchyme, but they do not enter it. As 
the cap splits, endothelia migrate through the fissure to form new vascular plexuses. The 
mechanism by which this happens is not understood, but we hypothesised that at least part 
of the pattern, the avoidance of the cap mesenchyme by the vasculature, may arise through 
the cap mesenchyme expressing anti-angiogenic signalling molecules. 
Certain class-3 semaphorins have a known capacity to act as anti-angiogenic signalling 
molecules. An example is semaphorin-3f (Sema3f; Bielenberg et al., 2004; Guttmann-Raviv 
et al., 2007; Parker et al., 2010; Buehler et al., 2013; Guo et al., 2013). Although classically 
thought of as an axonal guidance molecule, Sema3f is highly expressed in multiple non-
neuronal organs during development, such as the skin, lung, and kidney (Giger et al., 1998). 
Its functions in these tissue types are poorly understood. 
In vascular development, Sema3f inhibits angiogenesis by interacting with its receptors on 
the endothelial cell membrane, neuropilin-1 (Nrp1; its low-affinity receptor) and neuropilin-2 
(Nrp2; its high-affinity receptor; Guo et al., 2013; Sakurai et al., 2012). Sema3f/Nrp signalling 
results in the suppression of endothelial cell survival, proliferation, and migration (Guttmann-
Raviv et al., 2007; Procaccia et al., 2014; Nakayama et al., 2015).  
Here, we characterise the expression patterns of Sema3f, Nrp1, and Nrp2 in the developing 
kidney. We show that they are expressed in a manner perfectly compatible with the 
hypothesis that they mediate exclusion of vasculature from caps, but go on to show that they 
are not, in fact, required for this aspect of vascular plexus patterning.  
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Results and Discussion 
Selection of a cap mesenchyme-expressed, anti-angiogenic candidate gene 
We previously demonstrated that renal endothelia pattern around, but do not enter, the cap 
mesenchyme in the nephrogenic zone of the developing kidney (Munro et al., 2017; Fig. 1A). 
Patterning occurs in cycles throughout most of embryonic kidney development, and we 
hypothesised that anti-angiogenic signals produced by the cap mesenchyme might be 
responsible for it being avascular. To test this, we generated a list of criteria to be met by 
cap mesenchyme-expressed candidate genes whose proteins might inhibit angiogenesis 
(Fig. 1B). We reviewed the literature to produce a list of 39 known anti-angiogenic genes and 
used microarray data from the GenitoUrinary Development Molecular Anatomy Project 
(GUDMAP) database (Brunskill et al., 2009; Harding et al., 2011) to assess their relative 
expression in the cap mesenchyme (Fig. 2). Of the genes investigated, isthmin-1 (Ism1), 
semaphorin-3f (Sema3f), and suppressor of cytokine signalling-3 (Socs3) met our initial 
criteria as candidate genes as they are highly expressed in the cap mesenchyme during the 
embryonic (E15.5) and early postnatal phase (at least at one age between P0-P4; Fig. 1C 
and Fig. 2). 
The next condition to be met was that the relative expression of the gene had to be lower in 
the nephrogenic interstitium (which becomes vascularized) than the cap mesenchyme 
(which does not): this was true for all three of these candidate genes at E15.5 (Fig. 1D). The 
anti-angiogenic function of the protein also had to be mediated through cell non-autonomous 
signalling (i.e. via secretion from the cap mesenchyme or presentation on cap mesenchyme 
membranes so it can exert its effect on the nearby endothelia). Socs3 is a Stat-inhibiting, 
intracellular protein (Starr et al., 1997) and its anti-angiogenic effect is endothelial-cell 
autonomous (Stahl et al., 2012; Rao et al., 2015): it was therefore discounted as a possible 
candidate gene.  
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Ism1 and Sema3f are secreted proteins, and their anti-angiogenic properties are exerted 
when they bind to their receptors on the endothelial cell membrane: receptor-ligand binding 
leads to the activation of signalling pathways that prevent endothelial cell survival and 
proliferation (Guttmann-Raviv et al., 2007; Xiang et al., 2011; Rao et al., 2015). 
Consequently, the receptors for Ism1 and Sema3f would need to be expressed in the plexus 
endothelia for them to transduce their signals. The receptors for Ism1 are integrin alpha-V 
(Itgav; Zhang et al., 2011) and 78 kDa glucose-regulated protein homolog (Grp78; Chen et 
al., 2014), and, based on microarray data, they were expressed weakly in renal endothelia 
(Fig. 1E). In contrast, the expression of the Sema3f receptors, neuropilin-1 and neuropilin-2 
(Nrp1 and Nrp2, respectively), was high in renal endothelia (Fig. 1E). Based on these data, 
we further investigated the Sema3f/Nrp signalling pathway in vascular patterning in the 
nephrogenic zone.  
Complementary expression pattern of Sema3f and Nrp2 in the developing 
kidney 
The GUDMAP microarray data indicating that Sema3f is highly expressed in the cap 
mesenchyme at E15.5 has been validated at the RNA level by in situ hybridisation of whole-
mount kidneys (data made available on GUDMAP by the McMahon lab; Fig 3A-A’). Although 
GUDMAP has little data on renal Sema3f expression prior to E15.5, data from the Allen 
Brain Atlas (Lein et al., 2007) show that Sema3f is also expressed in the kidney at E11.5 and 
E13.5 (Fig 3B-C’). At the earliest stages of renal organogenesis (E10.5-E11.5), the kidney is 
predominantly avascular, despite being surrounded by blood vessels (Munro et al., 2017). 
As Sema3f is expressed throughout the metanephrogenic mesenchyme at E11.5 (Fig. 3B-
B’), its anti-angiogenic function could prevent premature renal vascularisation.  
To investigate the localisation of the Sema3f protein, we stained whole-mount kidneys at 
E12.5 and E15.5 with anti-Sema3f. Kidneys were cleared with benzyl alcohol/benzyl 
benzoate (BABB) prior to imaging. At E12.5, Sema3f localises in tubular epithelia (in 
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agreement with Villegas and Tufro, 2002) and in the presumptive cap mesenchyme (Fig. 3D). 
At E15.5, we assessed co-localisation of Sema3f with the cap mesenchyme marker, integrin 
alpha-8 (Müller et al., 1997). Sema3f staining was not exclusive to the cap mesenchyme: it 
was observed in tubular epithelia, the cap mesenchyme, and the nephrogenic interstitium 
(Fig 3E). This is unsurprising as Sema3f is a secreted protein whose localisation is not 
restricted to the cell that produces it. Indeed, Sema3f would be required to exit the cap to 
bind to, and inhibit, endothelia in the nephrogenic interstitium.  
To respond to Sema3f, the endothelia in the nephrogenic interstitium would have to express 
either Nrp1, Nrp2, or both. Confocal z-stack images of an E15.5 Nrp2-EGFP transgenic 
mouse kidney, made available on GUDMAP by Steven Potter’s lab, indicated that Nrp2 is 
expressed in proximal tubules and by an unknown cell type within the nephrogenic 
interstitium (Supplementary movie 1; adapted with permission from the Potter Lab). We 
examined whether the Nrp2+ cells within the nephrogenic interstitium were endothelial by co-
staining with anti-Nrp2 and anti-CD31 (an endothelial marker). The Nrp2+ cells were 
endothelial and were always present across the bifurcation site of the ureteric bud (42/42, 
100%, CI95% ± 1.19%; n = 42 bifurcation sites analysed in 1 kidney; Fig. 4A-C). Because new 
vascular plexuses form when endothelial cells migrate away from the bifurcation site (Munro 
et al., 2017; Fig. 4D), these Nrp2+ endothelia were situated in the precise location we would 
anticipate for them to be responding to Sema3f.  
Expression of Nrp1 and Nrp2 in the developing kidney and ureter 
Studies suggest that Nrp1 and Nrp2 are differentially expressed in arterial, venous, and 
lymphatic endothelia (Herzog et al., 2001). Nrp2 is preferentially expressed in lymphatic 
vessels and veins, whereas Nrp1 is expressed in arteries. We corroborated these findings by 
co-staining Nrp1+ and Nrp2+ endothelia with venous and lymphatic markers in the ureter (Fig. 
5A-C’). The Nrp2+ endothelia in the ureter are lymphatic and venous (based on morphology 
[Fig. 5A] and as shown by co-staining with anti-Lyve-1 [Fig. 5B] and anti-EphB4 [Fig. 5C], 
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markers for lymph and vein respectively). The Nrp1+ endothelia in the ureter are arterial (as 
shown by lack of co-staining with anti-Nrp2 and anti-EphB4; Fig. 5C’).  
In the E11.5 and E12.5 kidney, almost all renal blood vessels expressed Nrp2, but few 
vessels expressed Nrp1 (Fig. 6A, B). By E13.5, Nrp1 had become highly expressed in renal 
arteries (Fig. 6C-E). The endothelial plexuses in the E13.5 kidney had many Nrp2+ cells, but 
few discernible Nrp1+ cells. In contrast, by E18.5 the plexus endothelia expressed Nrp2 as 
well as Nrp1 (Fig 6E, F). Nrp2 is highly enriched in endothelial tip cells (Siemerink et al., 
2012). Based on the location of the Nrp2+ plexus endothelia at the vascular front (the site of 
new blood vessel formation), we speculate that these Nrp2+ cells are the endothelial tip cells 
in the kidney; however, there are no known specific endothelial tip cell markers to verify this 
hypothesis.  
In the ureter, anti-Nrp2 staining is very strong in lymphatic vessels (Fig 5A-C). We next 
explored whether Nrp2+ lymphatic vessels form within the kidney. To do this, we cleared 
whole-mount E15.5 kidneys with BABB prior to imaging. We demonstrate that Nrp2+ 
lymphatic vessels form rings around the ureter and that these vessels connect with the 
lymphatic vessels in the renal pelvis (Fig 7A-B). In agreement with previous studies (Tanabe 
et al., 2012), renal Nrp2+ lymphatic vessels extend along the segmental vasculature from the 
renal pelvis (Fig 7C). The Nrp2+ lymphatic vessels in the kidney and ureter are in connection 
with a network of Nrp2+ lymphatic vessels that supply the adrenal gland, gonad, 
mesonephros, and ureter (Fig 7A; Supplementary movie 2).  
Sema3f and Nrp2 are not required for exclusion of endothelia from the cap 
mesenchyme 
After confirming the complementary expression pattern of Sema3f and Nrp2 in the 
nephrogenic zone, we tested the hypothesis that their interaction repels endothelia from the 
caps. Genetic ablation of Sema3f did not result in vessels entering the cap mesenchyme, as 
shown by co-staining for anti-Six2 (cap mesenchyme marker), anti-collagen IV (blood vessel 
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and ureteric bud basement membrane marker), and anti-CD31 (endothelial marker; Fig. 8A, 
C). Endothelial patterning was also normal in Nrp2 null mouse kidneys (Fig. 8B, D), 
providing validation that signalling through the Sema3f/Nrp2 pathway is not required for 
normal vascular plexus patterning around the cap mesenchyme. 
In conclusion, we have demonstrated that, although Sema3f and its receptors (Nrp1/2) are 
expressed in a manner compatible with the hypothesis that their interaction excludes 
endothelia from the cap mesenchyme, signalling through the Sema3f/Nrp pathway is not 
required for vasculature repulsion from the cap. This lack of requirement for Sema3f and 
Nrp2 could be the result of redundancy with another pathway, the result of compensatory 
expression of other genes (such as other class-3 semaphorins) in response to their loss, or 
simply that they are not involved in this aspect of vascular patterning.  
We investigated the consequences of Sema3f and Nrp2 deletion on vascular plexus 
patterning around the cap mesenchyme; however, Sema3f is also expressed by tubular cells 
in the kidney (Villegas and Tufro, 2002), and we have not eliminated the possibility that 
tubular expression of Sema3f could guide blood vessel patterning around 
nephrons/collecting ducts. Future studies should aim to reveal the significance of Sema3f 
and Nrp2 expression in the development of the kidney.   
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Experimental procedures 
Databases 
Cap mesenchyme-expression of anti-angiogenic genes was examined using GUDMAP’s 
gene expression search tool 
(http://www.gudmap.org/gudmap/pages/database_homepage.html). The microarray 
heatmap data for each gene was taken from the ‘Developing Kidney (MOE430)’ and 
‘Developing Kidney (ST1)’ data sets (data retrieved May, 2017). The normalised heatmap 
data (red indicating high expression, blue indicating low expression, and black indicating 
expression that is close to the median) represents the binary logarithm of the average 
expression value of a given gene across an entire data set. For each probe set, experiments 
were performed in triplicate. Where there were two probe sets available for the expression of 
a given gene, the probe set with the most consistent data between replicate samples were 
shown. Where there were more than two probe sets available for the expression of a given 
gene, the probe set with the median values and/or colour were chosen for the analysis. The 
in situ hybridisation images showing Sema3f expression in the E15.5 kidney was submitted 
by the McMahon group (data retrieved from GUDMAP in May, 2017) and can be found at 
http://www.gudmap.org/gudmap/pages/gene.html?geneId=MGI%3A1096347. The confocal 
z-stack movie of the Nrp2-EGFP kidney was produced by the Potter group and can be found 
at http://www.gudmap.org/Resources/MouseStrains/Mouse_Strains_Summary.html under 
the heading ‘Mouse strains generated by external sources’ (data retrieved from GUDMAP in 
May, 2017). The in situ hybridisation images from the Allen Brain Atlas showing Sema3f 
expression at E11.5 can be found at http://developingmouse.brain-
map.org/experiment/show/100093437 (section 12/20; accessed May, 2017), and for E13.5 
can be found at http://developingmouse.brain-map.org/experiment/show/100076578 (section 
7/16; accessed May, 2017). Using the above Allen Brain Atlas links, renal Sema3f 
expression can be observed in sections 11-13 and 16-17 of the E11.5 mouse (out of 20 
sections), and in sections 6-10 and 15-16 of the E13.5 mouse (out of 16 sections). 
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Mice 
Wild-type embryonic tissues were obtained from CD-1 mice that were killed by qualified staff 
of a UK Home Office-licenced animal house following the guidelines set under Schedule 1 of 
the UK Animals (Scientific Procedures) Act 1986. Experiments were approved and 
performed in accordance with the institutional guidelines and regulations as set by the 
University of Edinburgh. Tissue from P0 Sema3f knockout embryos was obtained from 
Georgetown University facilities according to locally approved procedures. The Sema3f 
mutant line was maintained in accordance with the NIH Animal Care and Use Committee. 
The caudal portions of euthanized P0 Sema3f mice were sent at 4°C to the University of 
Edinburgh where the kidneys were dissected and immunostained (for details, see Davies, 
2006). The Sema3f knockout mouse line has previously been described (Walz et al., 2007). 
Sema3f mutant mice were bred for over 9 generations into a C57BL/6 genetic background 
(Charles River Laboratories, Frederick, MD). Tissue from E18.5 Nrp2 transgenic mouse 
embryos was kindly provided by Alex Kolodkin and Qiang Wang (Johns Hopkins University). 
Nrp2 mutant mice were bred into the C57BL/6 genetic background, and this mouse line has 
previously been described (Giger et al., 2000). 
Immunohistochemistry 
Embryonic kidneys were dissected as previously described (Davies, 2010). Kidneys were 
then fixed in methanol (pre-cooled at -20°C) for 1 hr. Fixed kidneys were either stored in 
methanol at -20°C (for up to 6 months) or directly processed following fixation. PBS was 
used to rinse off the methanol from the kidneys (3 x 20 mins) and the kidneys were blocked 
with 1x PBS with 5% donkey serum (Sigma, D9663) and 2.5% BSA (Sigma, A9647) for 1 hr-
overnight. Kidneys were incubated with the following primary antibodies overnight at 4°C: 
rat-anti-CD31 (1:100; BD Pharmingen; 550274), goat-anti-collagen IV (1:100; 
Merckmillipore; AB769), rat-anti-EphB4 (1:100; abcam; ab73259), rabbit-anti-laminin (1:100; 
Sigma; L9393), rabbit-anti-Lyve1 (1:100; Abcam; ab33682), rabbit-anti-Nrp1 (1:100; abcam; 
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ab81321), goat-anti-Nrp2 (1:100; R&D systems; AF567), mouse-anti-pan cytokeratin (1:100; 
Sigma; C2562), rabbit-anti-Sema3f (1:100; abcam; ab39956), rabbit-anti-Six2 (1:250; 
Proteintech; 11562-1-AP), goat-anti-mouse-integrin alpha 8 (1:100; R&D systems; AF4076). 
Kidneys were then rinsed in 1x PBS (3 x 5 mins, then 3 x 1 hr) and subsequently incubated 
in Alexa Fluor conjugated secondary antibodies overnight at 4°C (emission λ of 350, 488, 
594, 647; dilution of 1:200; Thermo Fisher Scientific). Finally, kidneys were washed in 1x 
PBS (3 x 5 mins, then 4 x 1 hr), before being mounted onto glass slides using Vectashield 
(Vectorlabs, H1000) as a mounting medium. Benzyl alcohol/benzyl benzoate (BABB) 
clearing whole-mount immunofluorescence was performed as previously described (Munro 
et al., 2017). BABB clearing was used for Fig. 3D-E and Fig. 7.  
Microscopy 
Images were captured using the Nikon A1R and Zeiss LSM800 confocal microscopes. 
Objective lenses of 4-60x were used (lenses were oil-immersed from 40x upwards).  
Statistics and data presentation 
95% confidence intervals for binary (yes/no) data were calculated using the formula 
t=1.64SQRT(pq/n)+1/2n, where t is the 95% confidence interval, p is the proportion positive, 
q is 1-p, and n is the number examined. IMARIS (version 8.3.1) and Adobe premiere pro CC 
(2015) were used to prepare the supplementary movies.   
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Figure legends 
 
Figure 1. Selection of Sema3f as a candidate gene for vascular plexus patterning in 
kidney development. (A) Cartoons portraying the relevant cell populations in the 
nephrogenic zone of the kidney (modified GUDMAP cartoons). Note that the vasculature 
forms within the nephrogenic interstitium and around the cap mesenchyme. (B) Criteria for 
candidate gene selection. (C) GUDMAP microarray heatmap data showing the expression of 
the top three anti-angiogenic candidate genes by the cap mesenchyme at E15.5 and P0-P4: 
reproduced under the terms of the GUDMAP licence for re-use. (D) Expression of the top 
three candidate genes in the nephrogenic interstitium at E15.5 (relative to the cap 
mesenchyme). (E) Expression of the receptors for Ism1 (Grp78 and Itgav) and Sema3f 
(Nrp1 and Nrp2) by various renal endothelial beds at E15.5.  
 
Figure 2. Microarray heatmap data from GUDMAP showing the relative expression of 
anti-angiogenic genes by the cap mesenchyme at E15.5 and P0-P4. This list of anti-
angiogenic genes is not exhaustive. Heatmap data is reproduced under the terms of the 
GUDMAP licence for re-use. 
 
Figure 3. Confirmation that Sema3f is expressed in the cap mesenchyme of the 
developing kidney. (A-A’) In situ hybridisation image showing Sema3f expression in the 
cap mesenchyme of the E15.5 kidney (from GUDMAP; submitted by the McMahon lab). (B-
C’) In situ hybridisation images showing Sema3f expression in the (B-B’) E11.5 and (C-C’) 
E13.5 kidney (image credit: Allen Institute). (D) E12.5 kidney co-stained with anti-Sema3f 
and anti-Gata3. Red blood cells are yellow (due to heme auto-fluorescence in the red and 
green channels as a result of tissue clearing). (E) E15.5 kidney co-stained with anti-Sema3f 
and anti-integrin alpha-8 (ITGA8). Negative control (secondary only) image was taken using 
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identical microscope settings. Scale bars = 100 µm (except from B-C’ where scale bar 
values are stated).  
 
Figure 4. Expression of Nrp2 by endothelial cells in the nephrogenic interstitium. (A) 
Nrp2+ cells within the nephrogenic interstitium are endothelial. (B) As the cap mesenchyme 
splits, Nrp2+ endothelia are present at the bifurcation site where new vascular plexuses form 
(white arrowhead shows an example). (C) Nrp2+ endothelia are positioned around the cap 
mesenchyme. (D) Cartoon illustrating the complementary expression pattern of Nrp2 and 
Sema3f in the nephrogenic zone. Green arrowheads indicate the direction of endothelial 
migration as cap mesenchymal populations split. Scale bars = 100 µm.  
 
Figure 5. Expression of Nrp1 and Nrp2 in the endothelia of the ureter. (A) Based on 
vessel morphology in the E18.5 ureter, veins (V; larger diameter vessel with loosely packed 
endothelia) are CD31+Nrp2+, whereas arteries (A; smaller diameter vessel with tightly 
packed endothelia) are CD31+Nrp2-. (B-C’) Based on co-staining in the E18.5 ureter, (B) 
lymphatic vessels are Nrp2+Lyve-1+CD31+, (C-C’) veins are Nrp2+EphB4+Nrp1-, and arteries 
are Nrp1+Nrp2-EphB4-. Macrophages (MΦ) are also present in B. A, artery; V, vein; LV, 
lymphatic vessel; MΦ, macrophages. Scale bars = 100 µm. 
 
Figure 6. Nrp1 and Nrp2 expression in the developing kidney. (A-C) Expression of Nrp1 
and Nrp2 by renal endothelia at E11.5-E13.5. (D) Cartoons illustrating the expression 
patterns of Nrp1 and Nrp2 and the position of the cap mesenchyme (CM) in the E11.5-E13.5 
kidney. (E-F) Nrp1 and Nrp2 expression in plexus endothelia at (E) E13.5 and (F) E18.5. 
Scale bars = 100 µm. 
 
Figure 7. Nrp2 expression in lymphatic endothelia. (A) A network of Nrp2+ lymphatic 
vessels surround the major arteries in the kidney, mesonephros, gonad, and adrenal gland 
(stitched confocal z-stacks; 2x2 tiles; 57 images per tile). (B) Renal Nrp2+ lymphatic vessels 
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connect with the Nrp2+ lymphatic vessels in the ureter (representative image of n = 4 
confocal z-stack images). (C) Lymphatic vessels form alongside the segmental vasculature. 
Red blood cells are magenta (due to heme auto-fluorescence in the red and blue channels 
as a result of tissue clearing). AG, adrenal gland. Scale bars = 100 µm. 
 
Figure 8. Sema3f and Nrp2 are not required for exclusion of blood vessels from the 
cap mesenchyme in the nephrogenic zone. (A-B) Genetic ablation of Sema3f had no 
effect on vascular patterning around the caps (representative images from n = 2-3 P0 mice; 
4-6 kidneys per genotype; 9-12 total fields of staining per genotype). (C-D) Genetic ablation 
of Nrp2 had no effect on vascular patterning around the caps (representative images from n 
= 1-3 E18.5 embryos; 2-6 total fields of staining per genotype). Asterisks in the genotyping 
gel images represent the embryos/pups whose kidneys are shown in the representative 
images. Scale bars = 100 µm.  
 
Supplementary figure legend 
Supplementary Movie 1. Confocal z-stack images of an E15.5 Nrp2-EGFP kidney. White 
arrows show examples of Nrp2+ cells in the nephrogenic interstitium. White arrowheads 
show examples of Nrp2+ proximal tubules. Video adapted from data generated by the Potter 
lab. 
 
Supplementary Movie 2. Tiled z-stack images of the Nrp2+ network of lymphatic vessels in 
the E15.5 kidney and adjacent organs. Vessels were rendered using the volume tool in 
IMARIS.   
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Figures 
 
Figure 1. Prepared for two columns. 
Figure 2. Prepared for two columns. 
Figure 3. Prepared for two columns.   
Figure 4. Prepared for two columns. 
Figure 5. Prepared for one column. 
Figure 6. Prepared for two columns. 
Figure 7. Prepared for two columns. 
Figure 8: Prepared for two columns. 
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Figure 1. Selection of Sema3f as a candidate gene for vascular plexus patterning in kidney development. (A) 
Cartoons portraying the relevant cell populations in the nephrogenic zone of the kidney (modified GUDMAP 
cartoons). Note that the vasculature forms within the nephrogenic interstitium and around the cap 
mesenchyme. (B) Criteria for candidate gene selection. (C) GUDMAP microarray heatmap data showing the 
expression of the top three anti-angiogenic candidate genes by the cap mesenchyme at E15.5 and P0-P4: 
reproduced under the terms of the GUDMAP licence for re-use. (D) Expression of the top three candidate 
genes in the nephrogenic interstitium at E15.5 (relative to the cap mesenchyme). (E) Expression of the 
receptors for Ism1 (Grp78 and Itgav) and Sema3f (Nrp1 and Nrp2) by various renal endothelial beds at 
E15.5.  
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Figure 2. Microarray heatmap data from GUDMAP showing the relative expression of anti-angiogenic genes 
by the cap mesenchyme at E15.5 and P0-P4. This list of anti-angiogenic genes is not exhaustive. Heatmap 
data is reproduced under the terms of the GUDMAP licence for re-use.  
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Figure 3. Confirmation that Sema3f is expressed in the cap mesenchyme of the developing kidney. (A-A’) In 
situ hybridisation image showing Sema3f expression in the cap mesenchyme of the E15.5 kidney (from 
GUDMAP; submitted by the McMahon lab). (B-C’) In situ hybridisation images showing Sema3f expression in 
the (B-B’) E11.5 and (C-C’) E13.5 kidney (image credit: Allen Institute). (D) E12.5 kidney co-stained with 
anti-Sema3f and anti-Gata3. Red blood cells are yellow (due to heme auto-fluorescence in the red and green 
channels as a result of tissue clearing). (E) E15.5 kidney co-stained with anti-Sema3f and anti-integrin 
alpha-8 (ITGA8). Negative control (secondary only) image was taken using identical microscope settings. 
Scale bars = 100 µm (except from B-C’ where scale bar values are stated).  
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Figure 4. Expression of Nrp2 by endothelial cells in the nephrogenic interstitium. (A) Nrp2+ cells within the 
nephrogenic interstitium are endothelial. (B) As the cap mesenchyme splits, Nrp2+ endothelia are present at 
the bifurcation site where new vascular plexuses form (white arrowhead shows an example). (C) Nrp2+ 
endothelia are positioned around the cap mesenchyme. (D) Cartoon illustrating the complementary 
expression pattern of Nrp2 and Sema3f in the nephrogenic zone. Green arrowheads indicate the direction of 
endothelial migration as cap mesenchymal populations split. Scale bars = 100 µm.  
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Figure 5. Expression of Nrp1 and Nrp2 in the endothelia of the ureter. (A) Based on vessel morphology in 
the E18.5 ureter, veins (V; larger diameter vessel with loosely packed endothelia) are CD31+Nrp2+ 
whereas arteries (A; smaller diameter vessel with tightly packed endothelia) are CD31+Nrp2-. (B-C’) Based 
on co-staining in the E18.5 ureter, (B) lymphatic vessels are Nrp2+Lyve-1+CD31+, (C-C’) veins are 
Nrp2+EphB4+Nrp1- and arteries are Nrp1+Nrp2-EphB4-. Macrophages (MΦ) are also present in B. A, 
artery; V, vein; LV, lymphatic vessel; MΦ, macrophages. Scale bars = 100 µm.  
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Figure 6. Nrp1 and Nrp2 expression in the developing kidney. (A-C) Expression of Nrp1 and Nrp2 by renal 
endothelia at E11.5-E13.5. (D) Cartoons illustrating the expression patterns of Nrp1 and Nrp2 and the 
position of the cap mesenchyme (CM) in the E11.5-E13.5 kidney. (E-F) Nrp1 and Nrp2 expression in plexus 
endothelia at (E) E13.5 and (F) E18.5. Scale bars = 100 µm.  
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Figure 7. Nrp2 expression in lymphatic endothelia. (A) A network of Nrp2+ lymphatic vessels surround the 
major arteries in the kidney, mesonephros, gonad, and adrenal gland (stitched confocal z-stacks; 2x2 tiles; 
57 images per tile). (B) Renal Nrp2+ lymphatic vessels connect with the Nrp2+ lymphatic vessels in the 
ureter (representative image of n = 4 confocal z-stack images). (C) Lymphatic vessels form alongside the 
segmental vasculature. Red blood cells are magenta (due to heme auto-fluorescence in the red and blue 
channels as a result of tissue clearing). AG, adrenal gland. Scale bars = 100 µm.  
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Figure 8. Sema3f and Nrp2 are not required for exclusion of blood vessels from the cap mesenchyme in the 
nephrogenic zone. (A-B) Genetic ablation of Sema3f had no effect on vascular patterning around the caps 
(representative images from n = 2-3 P0 mice; 4-6 kidneys per genotype; 9-12 total fields of staining per 
genotype). (C-D) Genetic ablation of Nrp2 had no effect on vascular patterning around the caps 
(representative images from n = 1-3 E18.5 embryos; 2-6 total fields of staining per genotype). Asterisks in 
the genotyping gel images represent the embryos/pups whose kidneys are shown in the representative 
images. Scale bars = 100 µm.  
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